SPL7013 Gel - Male Tolerance Study

Inclusion Criteria: Provision of written informed consent Healthy males aged 18 years or older HIV negative Reports vaginal intercourse in the past 12 months Agrees to abstain from vaginal, anal (receptive and insertive) and oral sexual intercourse, and agrees to refrain from masturbation during the 7 days of product use until after the End-of-Treatment (Day 7) study visit Exclusion Criteria: Known or suspected allergy to any component of the study products or similar ingredients in other products History of significant drug reaction or allergy Recent history (within 12 months) or presence at screening of contact dermatitis or other dermatological condition Recent history (within three months of Screening) of a sexually transmitted infection (STI) Current signs or symptoms of UTI and/or STI at Screening or Baseline Positive urine leukocyte esterase test (≥ trace) Biochemical and/or haematological parameters outside the laboratory's normal reference ranges at Screening Evidence of genital piercing, ulceration, genital dermatoses, tinea cruris or other dermatological condition of the genitalia or upper thighs Genital pain or discomfort at Screening or Baseline Any other abnormal finding on physical examination or other medical condition